Table 3.
Detail | Terbinafine 12 weeks | Terbinafine 16 weeks | Itraconazole 3 cycles | Itraconazole 4 cycles |
---|---|---|---|---|
Clinical cure | 59/110 (54) | 59/98 (60) | 34/107 (32) | 35/109 (32) |
Mycological cure | 81/107 (76) | 80/99 (81) | 41/107 (38) | 53/108 (49) |
Complete cure | 49/107 (46) | 54/98 (55) | 25/107 (23) | 28/108 (26) |
Clinical efficacy | 67/102 (66) | 67/95 (71) | 29/102 (28) | 35/104 (34) |
Global assessment: | ||||
Patients* | 86/109 (79) | 78/99 (79) | 47/107 (44) | 57/109 (52) |
Physicians† | 87/110 (79) | 84/99 (85) | 56/107 (52) | 60/109 (55) |
Patients who assessed their therapeutic results as good or very good.
Physicians who rated patients’ responses to treatment as good or very good.